• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume10, Issue1

Retrospective evaluation of the outcome of initial trial without catheter in benign prostatic hyperplasia patients with intravesical prostatic protrusion of different grades presented with acute urinary retention

    Dr. Bijit Lodh, Dr. Ranjit Reang

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 1, Pages 5227-5231

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Intravesical prostatic protrusion (IPP), a unique anatomical configuration has recently become a very significant component in the evaluation of BPH patients. Hence the present study aimed to evaluate the outcome of initial trial without catheter in Benign prostatic hyperplasia patients with IPP of different grades presented with acute urinary retention.
Materials & methods: The retrospective study conducted at Urology unit, Department of General Surgery, Agartala Government Medical College, Agartala from September 2018 to January 2022. Patient fulfilling the inclusion criteria were included in the study. Data sheet was completed where the patient’s demographics, IPSS, PSA, total prostate volume, IPP and its grade, peak flow rate of voided patients, PVRU was recorded and analyzed.
Results: Mean patient age was 69.76±9.54 years (range 52 to 87) in group A, 67.80±7.70 years (range 54-82) in group B and 66.23±8.84 years (range 51-81) in group C. Mean value of IPP was greater in group C with statistically significant result with p value <0.01 comparing group A and C. Correlation between IPP with other pre-treatment parameters show significant results with TPV, TZV, TZI, QoL, PUFR & PVRU.
Conclusion- IPP is a helpful indicator for determining whether a voiding trial after ARU was successful. A trial without a catheter may be advantageous for BPH patients with grade 1 IPP. Patients with grade III IPP, on the other hand, are less likely to do so and would need a more thorough surgical intervention.
Keywords:
    catheterization prostate prostatic hyperplasia Ultrasonography urination
  • PDF (279 K)
  • XML
(2023). Retrospective evaluation of the outcome of initial trial without catheter in benign prostatic hyperplasia patients with intravesical prostatic protrusion of different grades presented with acute urinary retention. European Journal of Molecular & Clinical Medicine, 10(1), 5227-5231.
Dr. Bijit Lodh, Dr. Ranjit Reang. "Retrospective evaluation of the outcome of initial trial without catheter in benign prostatic hyperplasia patients with intravesical prostatic protrusion of different grades presented with acute urinary retention". European Journal of Molecular & Clinical Medicine, 10, 1, 2023, 5227-5231.
(2023). 'Retrospective evaluation of the outcome of initial trial without catheter in benign prostatic hyperplasia patients with intravesical prostatic protrusion of different grades presented with acute urinary retention', European Journal of Molecular & Clinical Medicine, 10(1), pp. 5227-5231.
Retrospective evaluation of the outcome of initial trial without catheter in benign prostatic hyperplasia patients with intravesical prostatic protrusion of different grades presented with acute urinary retention. European Journal of Molecular & Clinical Medicine, 2023; 10(1): 5227-5231.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 10
  • PDF Download: 22
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus